1 year return (CAGR)
528.15%
Climb Bio Inc Exchange (NASDAQ, USD)
CLYM
14.11
-0.10 (-0.66%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
78.02%
5 year return (CAGR)
-11.08%
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
858.67M
Price/Sales
-
Ent value
821.31M
Price/Book
3.58
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-13.01%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 14.80 |
| Daily high | 15.07 |
| Daily low | 14.16 |
| Daily Volume | 1.49M |
| All-time high | 28.61 |
| 1y analyst estimate | 22.86 |
| Beta | 0.08 |
| EPS (TTM) | -0.76 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 9 Mar 2026 |
Downside potential
Loading...
Downside potential data
| CLYM | S&P500 | |
| Current price drop from All-time high | -50.68% | -3.06% |
| Highest price drop | -96.05% | -56.47% |
| Date of highest drop | 8 Apr 2025 | 9 Mar 2009 |
| Avg drop from high | -80.19% | -10.68% |
| Avg time to new high | 182 days | 12 days |
| Max time to new high | 1258 days | 1805 days |
News
